Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Shape design of high drug payload nanoparticles for more effective cancer therapy.

Li W, Zhang X, Hao X, Jie J, Tian B, Zhang X.

Chem Commun (Camb). 2013 Dec 4;49(93):10989-91. doi: 10.1039/c3cc46718j.

PMID:
24136236
[PubMed - indexed for MEDLINE]
2.

[Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles].

Xi N, Hou LB.

Zhong Yao Cai. 2010 Apr;33(4):610-3. Chinese.

PMID:
20845792
[PubMed - indexed for MEDLINE]
3.

Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.

Wang A, Li S.

BMC Biotechnol. 2008 May 4;8:46. doi: 10.1186/1472-6750-8-46.

PMID:
18454874
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.

Yin P, Wang Y, Qiu Y, Hou L, Liu X, Qin J, Duan Y, Liu P, Qiu M, Li Q.

Int J Nanomedicine. 2012;7:3961-9. doi: 10.2147/IJN.S32063. Epub 2012 Jul 27.

PMID:
22888239
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Carrier-free, functionalized drug nanoparticles for targeted drug delivery.

Li W, Yang Y, Wang C, Liu Z, Zhang X, An F, Diao X, Hao X, Zhang X.

Chem Commun (Camb). 2012 Aug 21;48(65):8120-2. doi: 10.1039/c2cc33214k. Epub 2012 Jul 6.

PMID:
22766919
[PubMed - indexed for MEDLINE]
6.

Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.

Hong M, Zhu S, Jiang Y, Tang G, Sun C, Fang C, Shi B, Pei Y.

J Control Release. 2010 Jan 4;141(1):22-9. doi: 10.1016/j.jconrel.2009.08.024. Epub 2009 Sep 4.

PMID:
19735683
[PubMed - indexed for MEDLINE]
7.

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.

Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC.

J Control Release. 2008 May 8;127(3):208-18. doi: 10.1016/j.jconrel.2008.01.013. Epub 2008 Feb 7.

PMID:
18336946
[PubMed - indexed for MEDLINE]
8.

PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.

Jiang X, Xin H, Sha X, Gu J, Jiang Y, Law K, Chen Y, Chen L, Wang X, Fang X.

Int J Pharm. 2011 Nov 28;420(2):385-94. doi: 10.1016/j.ijpharm.2011.08.052. Epub 2011 Sep 6.

PMID:
21920419
[PubMed - indexed for MEDLINE]
9.
10.

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.

Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.

Int J Pharm. 2010 Dec 15;402(1-2):238-47. doi: 10.1016/j.ijpharm.2010.10.005. Epub 2010 Oct 8.

PMID:
20934500
[PubMed - indexed for MEDLINE]
11.

Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.

Svenson S, Wolfgang M, Hwang J, Ryan J, Eliasof S.

J Control Release. 2011 Jul 15;153(1):49-55. doi: 10.1016/j.jconrel.2011.03.007. Epub 2011 Mar 23.

PMID:
21406204
[PubMed - indexed for MEDLINE]
Free Article
12.

Linear-dendritic drug conjugates forming long-circulating nanorods for cancer-drug delivery.

Zhou Z, Ma X, Jin E, Tang J, Sui M, Shen Y, Van Kirk EA, Murdoch WJ, Radosz M.

Biomaterials. 2013 Jul;34(22):5722-35. doi: 10.1016/j.biomaterials.2013.04.012. Epub 2013 Apr 29.

PMID:
23639529
[PubMed - indexed for MEDLINE]
13.

Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration.

Nekkanti V, Venkateswarlu V, Ansari KA, Pillai R.

Curr Drug Deliv. 2011 Nov;8(6):661-6.

PMID:
22313161
[PubMed - indexed for MEDLINE]
14.

Ketal containing amphiphilic block copolymer micelles as pH-sensitive drug carriers.

Lee I, Park M, Kim Y, Hwang O, Khang G, Lee D.

Int J Pharm. 2013 May 1;448(1):259-66. doi: 10.1016/j.ijpharm.2013.03.017. Epub 2013 Mar 19.

PMID:
23524123
[PubMed - indexed for MEDLINE]
15.

Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.

Su Z, Shi Y, Xiao Y, Sun M, Ping Q, Zong L, Li S, Niu J, Huang A, You W, Chen Y, Chen X, Fei J, Tian J.

Int J Pharm. 2013 Apr 15;447(1-2):281-92. doi: 10.1016/j.ijpharm.2013.01.068. Epub 2013 Feb 7.

PMID:
23396258
[PubMed - indexed for MEDLINE]
16.

Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.

Yu DH, Lu Q, Xie J, Fang C, Chen HZ.

Biomaterials. 2010 Mar;31(8):2278-92. doi: 10.1016/j.biomaterials.2009.11.047. Epub 2010 Jan 6.

PMID:
20053444
[PubMed - indexed for MEDLINE]
17.

Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.

Hu Y, Xie J, Tong YW, Wang CH.

J Control Release. 2007 Mar 12;118(1):7-17. Epub 2006 Dec 6.

PMID:
17241684
[PubMed - indexed for MEDLINE]
18.

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.

J Control Release. 2009 Jan 5;133(1):11-7. doi: 10.1016/j.jconrel.2008.09.086. Epub 2008 Oct 9.

PMID:
18950666
[PubMed - indexed for MEDLINE]
19.

Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.

Martins S, Tho I, Reimold I, Fricker G, Souto E, Ferreira D, Brandl M.

Int J Pharm. 2012 Dec 15;439(1-2):49-62. doi: 10.1016/j.ijpharm.2012.09.054. Epub 2012 Oct 6.

PMID:
23046667
[PubMed - indexed for MEDLINE]
20.

Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.

Zhang X, Pan W, Gan L, Zhu C, Gan Y, Nie S.

Chem Pharm Bull (Tokyo). 2008 Dec;56(12):1645-50.

PMID:
19043233
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk